Analytics firm predicts global psoriasis market to grow twofold by 2030

UK-based analytics firm Globaldata estimates that the market for psoriasis treatments will grow from USD 14.2bn to USD 27.5bn before 2030 – this growth will be based on eight upcoming drug candidates.
Photo: Merck KGaA / PR
Photo: Merck KGaA / PR
by ULRICH QUISTGAARD, translated by daniel pedersen

The international market for drugs against the skin disease psoriasis will annually grow by 6.8 percent on average by 2030, when the market will total USD 27.5bn, UK-based analytics firm Globaldata reports in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading